Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.44 USD | -0.40% | -1.59% | +26.53% |
07/05 | Cogent Biosciences Q1 Loss Widens | MT |
07/05 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.53% | 71Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-2.74% | 2.2TCr | |
-14.15% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Wedbush Adjusts Price Target on Cogent Biosciences to $20 From $19, Maintains Outperform Rating